Data specifications

Definition: The ratio of cancer patients aged 18 years or younger who were newly enrolled in Phase 1 to 4 clinical trials (e.g., cancer-related therapeutic clinical trials or clinical research studies) to the total number of cancer patients aged 18 years or younger who were newly referred to children’s cancer treatment centres